Global Anticoccidial Drugs Market: By Type Of Animal, By Type Of Drugs, By Distribution Channels, and Region Forecast 2019-2030
Anticoccidial Drugs Market size was valued at US$ 1,142.60 million in 2023 and is poised to grow at a CAGR of 8.5% from 2024 - 2030. Market is one of the common poultry disease, which is caused by the parasite called as coccidian protozoa. It is highly resistant to harsh, rough environment and disinfectants. Market exists in the intestinal tract and undergoes multiplication to cause damage to the tissues, in turn, impede with the absorption of nutrients and digestion of food that may lead to the dehydration of body and blood loss.
Damaging of tissue in the animal may make the bird more infection prone to bacteria such as salmonella and clostridia. The disease transfers from one to other by contact with infected litter, faeces or damaged tissue. Coccidiosis is prevented by maintaining litter management and proper sanitation. Anticoccidial medications are used in conventional animal feeding, which is usually added to animal feed for prevention of coccidiosis. Rising Population pool, stability in economic conditions are leading to the rise in demand for foods with rich proteins, especially in the developing nations. Companies in veterinary healthcare were well established for addressing the growth of emerging markets towards the demand for the high-protein diets. Continuous investments for the innovations and the technological advancements for the development of animal health drugs.
Study Period
2024-2030Base Year
2023CAGR
8.5%Largest Market
North AmericaFastest Growing Market
Asia Pacific
Increasing prophylactic usage of anticoccidial drugs and rise in demand for the meat products are the major factors which are driving the growth of the anticoccidial drugs market. Furthermore, the feasible regulatory framework for the development and approval of the products and increase in governments spending on the healthcare of companion animals, increasing safety concerns about food and health of animals, improving prices and quality of meat and dairy product globally are the factors which are fuelling the growth of the market globally. However, lack of awareness, high prices of the raw materials and cost of the products may hinder the Additives in Animal Feed Market growth.
Anticoccidial Drugs Market is segmented as North America, Asia-Pacific, Europe, the Middle East & Africa, and Latin America. North America is dominating the market, majorly U.S, Canada and Mexico owing to the precautionary use of the anticoccidials in the veterinary feed. The European market is propelled due to the excessive rise in consumption of meat, especially France, Germany, Spain and UK. However, Asia Pacific market is anticipated to be as the speedy growing region in anticoccidials market owing to the large pool of population increase in demand for meat and meat proteins in countries like India, Malaysia, and China etc.
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
Report Study Period |
2024-2030 |
|
Market Size in 2023 |
US$ 1,142.60 million |
|
Market CAGR |
8.5% |
|
By Type of Animal |
|
|
By Type of Drugs |
|
|
By Distribution Channel |
|
|
By Region |
|
Download Free Sample Report
The global anticoccidial drugs market size was valued at US$ 1,142.60 million in 2023 and is projected to grow at a CAGR of 8.5% from 2024 - 2030.
The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).
In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.
The anticoccidial drugs market has been experiencing steady growth driven by increasing demand for poultry and livestock products along with the rising prevalence of coccidiosis in animals, coupled with ongoing research and development efforts for improved treatments.
| 1.Executive Summary |
| 2.Global Anticoccidial Drugs Market Introduction |
| 2.1.Global Anticoccidial Drugs Market - Taxonomy |
| 2.2.Global Anticoccidial Drugs Market - Definitions |
| 2.2.1.Type of Animal |
| 2.2.2.Type of Drugs |
| 2.2.3.Distribution Channel |
| 2.2.4.Region |
| 3.Global Anticoccidial Drugs Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4.Global Anticoccidial Drugs Market Analysis, 2019 - 2023 and Forecast 2024 - 2030 |
| 4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5.Global Anticoccidial Drugs Market By Type of Animal, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 5.1. Swine |
| 5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Poultry |
| 5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Ovine |
| 5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 5.4. Bovine |
| 5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.4.3. Market Opportunity Analysis |
| 5.5. Equine |
| 5.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.5.3. Market Opportunity Analysis |
| 5.6. Canine |
| 5.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.6.3. Market Opportunity Analysis |
| 5.7. Aquaculture |
| 5.7.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.7.3. Market Opportunity Analysis |
| 6.Global Anticoccidial Drugs Market By Type of Drugs, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 6.1. Sulpha drugs |
| 6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Amprolium |
| 6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Quinolones |
| 6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Ionophores |
| 6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 6.5. Others |
| 6.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.5.3. Market Opportunity Analysis |
| 7.Global Anticoccidial Drugs Market By Distribution Channel, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 7.1. Veterinary hospitals |
| 7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Online Pharmacy |
| 7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Retail Pharmacy |
| 7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 8.Global Anticoccidial Drugs Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 8.1. North America |
| 8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Europe |
| 8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Asia Pacific (APAC) |
| 8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Middle East and Africa (MEA) |
| 8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 8.5. Latin America |
| 8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.5.3. Market Opportunity Analysis |
| 9.North America Anticoccidial Drugs Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 9.1. Type of Animal Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1.Swine |
| 9.1.2.Poultry |
| 9.1.3.Ovine |
| 9.1.4.Bovine |
| 9.1.5.Equine |
| 9.1.6.Canine |
| 9.1.7.Aquaculture |
| 9.2. Type of Drugs Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1.Sulpha drugs |
| 9.2.2.Amprolium |
| 9.2.3.Quinolones |
| 9.2.4.Ionophores |
| 9.2.5.Others |
| 9.3. Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1.Veterinary hospitals |
| 9.3.2.Online Pharmacy |
| 9.3.3.Retail Pharmacy |
| 9.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.4.1.United States of America (USA) |
| 9.4.2.Canada |
| 10.Europe Anticoccidial Drugs Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 10.1. Type of Animal Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Swine |
| 10.1.2.Poultry |
| 10.1.3.Ovine |
| 10.1.4.Bovine |
| 10.1.5.Equine |
| 10.1.6.Canine |
| 10.1.7.Aquaculture |
| 10.2. Type of Drugs Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Sulpha drugs |
| 10.2.2.Amprolium |
| 10.2.3.Quinolones |
| 10.2.4.Ionophores |
| 10.2.5.Others |
| 10.3. Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Veterinary hospitals |
| 10.3.2.Online Pharmacy |
| 10.3.3.Retail Pharmacy |
| 10.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Germany |
| 10.4.2.France |
| 10.4.3.Italy |
| 10.4.4.United Kingdom (UK) |
| 10.4.5.Spain |
| 11.Asia Pacific (APAC) Anticoccidial Drugs Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 11.1. Type of Animal Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Swine |
| 11.1.2.Poultry |
| 11.1.3.Ovine |
| 11.1.4.Bovine |
| 11.1.5.Equine |
| 11.1.6.Canine |
| 11.1.7.Aquaculture |
| 11.2. Type of Drugs Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Sulpha drugs |
| 11.2.2.Amprolium |
| 11.2.3.Quinolones |
| 11.2.4.Ionophores |
| 11.2.5.Others |
| 11.3. Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Veterinary hospitals |
| 11.3.2.Online Pharmacy |
| 11.3.3.Retail Pharmacy |
| 11.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.China |
| 11.4.2.India |
| 11.4.3.Australia and New Zealand (ANZ) |
| 11.4.4.Japan |
| 11.4.5.Rest of APAC |
| 12.Middle East and Africa (MEA) Anticoccidial Drugs Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 12.1. Type of Animal Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Swine |
| 12.1.2.Poultry |
| 12.1.3.Ovine |
| 12.1.4.Bovine |
| 12.1.5.Equine |
| 12.1.6.Canine |
| 12.1.7.Aquaculture |
| 12.2. Type of Drugs Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Sulpha drugs |
| 12.2.2.Amprolium |
| 12.2.3.Quinolones |
| 12.2.4.Ionophores |
| 12.2.5.Others |
| 12.3. Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Veterinary hospitals |
| 12.3.2.Online Pharmacy |
| 12.3.3.Retail Pharmacy |
| 12.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.GCC Countries |
| 12.4.2.South Africa |
| 12.4.3.Rest of MEA |
| 13.Latin America Anticoccidial Drugs Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 13.1. Type of Animal Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.Swine |
| 13.1.2.Poultry |
| 13.1.3.Ovine |
| 13.1.4.Bovine |
| 13.1.5.Equine |
| 13.1.6.Canine |
| 13.1.7.Aquaculture |
| 13.2. Type of Drugs Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Sulpha drugs |
| 13.2.2.Amprolium |
| 13.2.3.Quinolones |
| 13.2.4.Ionophores |
| 13.2.5.Others |
| 13.3. Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Veterinary hospitals |
| 13.3.2.Online Pharmacy |
| 13.3.3.Retail Pharmacy |
| 13.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Brazil |
| 13.4.2.Mexico |
| 13.4.3.Rest of LA |
| 14. Competition Landscape |
| 14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 14.2.1.Eli Lilly (Elanco) |
| 14.2.2.Virbac |
| 14.2.3.Ceva Santé Animale |
| 14.2.4.Zoetis |
| 14.2.5.Merck Animal Healthcare |
| 14.2.6.Smartvet Inc. |
| 14.2.7.Intas |
| 14.2.8.Jurox |
| 14.2.9.Dosch Pharma |
| 15. Research Methodology |
| 16. Appendix and Abbreviations |
Key Market Players
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthcare domain, encompassing pharmaceuticals, medical devices, and diagnostics. A graduate in Pharmacy, he possesses a strong foundation in the intricacies of the healthcare sector. He further enhanced his expertise by pursuing an MBA in Pharmaceuticals, equipping him with valuable business acumen. His analytical skills and market insights have contributed to strategic decision-making and enhanced market positioning for various healthcare organizations. Committed to driving innovation and excellence, Muni continues to seek opportunities to improve healthcare delivery through data-driven insights.
Download Free Sample
